April 13, 20215 yr A human trial to test a new immune drug capable protecting people against HIV infections has led to a 97 per cent success rate, according to scientists at Scripps Research in San Diego, California. In fact, the trial has been so promising that vaccine giant Moderna has agreed to join the next stage of the development of the drug, which is capable of stimulating a rare set of immune cells that play a key role in fighting the fast-mutating human immunodeficiency virus (HIV). https://www.cityam.com/new-immune-drug-may-be-aids-cure-as-hiv-trial-show-97-per-cent-success-rate/
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.